Last reviewed · How we verify
NCT04943328: TRESTI
Cemented TrendHip® - Multicenter PMCF Study on Total Indications
NA trial testing Total Hip Arthroplasty in Coxarthrosis; Primary in 119 participants. Participants enrolled and being followed up; not accepting new ones.
8 May 2023
Quick facts
| Lead sponsor | Aesculap AG |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 119 |
| Start date | 12 October 2021 |
| Primary completion | 8 May 2023 |
| Estimated completion | 8 May 2028 |
| Sites | 4 locations across Germany |
Drugs / interventions tested
- Total Hip Arthroplasty
Conditions studied
- Coxarthrosis; Primary — all drugs for Coxarthrosis; Primary →
- Coxarthrosis; Post-Traumatic — all drugs for Coxarthrosis; Post-Traumatic →
- Necrosis, Femur Head — all drugs for Necrosis, Femur Head →
- Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
Sponsor
Aesculap AG — full company profile →
Who can join
18 and older, any sex, with Coxarthrosis; Primary or Coxarthrosis; Post-Traumatic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This Post Market Clinical Follow-Up (PMCF) study to evaluate the performance and safety of the cemented TrendHip® stem in a prospective follow-up study with patients who underwent a hip arthroplasty with the investigational product (representative of usual clinical practice), at two follow-up examinations
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04943328
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Total Hip Arthroplasty
Trials testing the same drug.
- NCT06640764 — Multicentre SMS Study - FR · recruiting
- NCT06499038 — The Ace Avanteon Study - A Randomized Controled Trial · NA · recruiting
- NCT06342843 — Direct Superior Approach Versus PosteroLateral Approach in Total Hip Arthroplasty (SPLAsH) · NA · recruiting
- NCT07409909 — Total Hip Arthroplasty Versus Bipolar Hemiarthroplasty for Treatment of Intracapsular Displaced Fracture Neck Femur in E · NA · completed
- NCT05357664 — PINNACLE® DM RSA Study · NA · terminated
Other Aesculap AG trials
Trials by the same sponsor.
- NCT05441618 — Post Market Clinical Follow-Up Study on the Performance and Safety of Lyoplant® · completed
- NCT06298500 — Clinical Performance of HISTOACRYL® LAPFIX - CANNULA for Laparoscopic Inguinal Hernia Repair · completed
- NCT05944081 — Postmarket Clinical Follow-Up Study on Arcadius XP L® Interbody Fusion Device · withdrawn
- NCT06055946 — Symmcora® Long-term Bidirectional Barbed Suture for Anastomosis in Patients Undergoing Robot Assisted Radical Prostatect · completed
- NCT05182320 — Study Measuring the Effects of Patient Data for Total Hip and Total Knee Arthroplasty Patients Using an APP Based Sensor · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04943328 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aesculap AG
- Last refreshed: 24 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04943328.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing